TickerGuard
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Magnera Corp placeholder (MAGN)

Consumer Defensive Household & Personal Products
13.30 $
-0.6% vs. previous close
Closing price · As of: 31. Jul 2026
🔔 Watch stock

Stock Watch

Stock Watch will tell you what changes at Magnera Corp placeholder.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Trading Day

Previous Close
13.30$
Open
13.20$
Day High
13.30$
Day Low
12.80$
Volume
386,878shares

Key levels of the most recently completed trading day — not a live quote.

52-Week Range

52-Week Low 52-Week High
8.00 $ 15.30 $
11/19/2025 01/06/2026

Current price 13.30 $ — 73% of the range above the low.

Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.

Basics

Market Cap
0.5$B
Shares Outstanding
36Mio.
Float
78.6%
Beta

Performance

Perf. 1M
4.10%
Perf. 3M
33.30%
Perf. 6M
-21.20%
YTD Performance (%)
-20.40%
52-Week-High Distance
-20.0%
Perf. 1Y
6.43%
Perf. 3Y
-70.02%
Perf. 5Y
-92.98%
Perf. 10Y
-93.94%
Perf. Since Inception
52.42%

Technical Indicators

MA 38 Days
12.70$
MA 50 Days
12.30$
MA 200 Days
12.00$
RSI (14)
52.8
Volatility 30 Days
43.3%
Volatility 250 Days
58.8%

Calculated from the price history · as of 08/03/2026

Valuation

P/E
Forward P/E
13.7
PEG
4.2
P/B
P/S
0.1
EV/EBITDA
84.7
Price/FCF
3.7

Profitability

Gross Margin
11.3%
EBIT Margin
Net Margin
-3.4%
Return on Equity
-10.3%
Return on Assets
2.0%

Balance Sheet & Safety

Equity Ratio
Debt/Equity
Altman Z″
4.88
Piotroski
7 out of 9

Growth

Sales Growth Last Quarter
-3.40%
EPS Growth Last Quarter
0.00%
Sales Growth (Year)
46.50%
Forward Sales Growth
3.38%
Forward EPS Growth
927.30%

Dividend

This stock currently pays no dividend.

Quality & Screener

Stage
1
RS Rating
49
EPS Rating
42
Piotroski
7 out of 9
Fundamental Rating
C (53 out of 100)
Altman Z″
4.88

AI Rating

Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built

Growth Score

5 of 10 Solid growth

Ten checks against the annual reports — each one passed counts a point.

  • Revenue grows by more than 15% a year over three years 29.0% passed
  • More than 10% revenue growth is expected for the coming year 3.4% failed
  • Share count grows by less than 3% a year 1.0% passed
  • Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 47.6% passed
  • Gross margin at 40% or higher and without meaningful erosion 9.0% failed
  • Goodwill from acquisitions does not grow faster than revenue 16.6% failed
  • Net debt below twice EBITDA 9.0 x EBITDA failed
  • Operating cash flow covers the profits of the last three years 661 m passed
  • Return on capital at 15% or higher, or up versus two years ago 2.8% passed
  • Insiders hold at least 10% or are net buyers 1.2% failed

A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail

Analysts & Price Target

Current Price 13.30 $
Price Target (average) 16.00 $

The price target sits 20.3% above the current price.

Consensus
Hold
Analyst Ratings
2
Distribution of Recommendations
Strong Buy 0
Buy 0
Hold 2
Sell 0
Strong Sell 0

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Estimates by Fiscal Year

Estimates by Fiscal Year
Fiscal Year EPS Estimate ($) EPS Range ($) Revenue Estimate ($M) Expected Growth Analysts
09/30/2026 0.93 0.16 – 1.70 3,402 128.0% 2
09/30/2027 1.68 1.22 – 2.15 3,485 81.0% 2

Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.

Next Reporting Date

6. Aug 2026 · before the open · Q2 2026
Expected Earnings per Share
0.31 $

Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q4 · 702.0 $M Q4 2025: Q1 · 824.0 $M Q1 2025: Q2 · 839.0 $M Q2 2025: Q3 · 839.0 $M Q3 2025: Q4 · 792.0 $M Q4 2026: Q1 · 796.0 $M Q1

Source: fundamental data

Compare with other stocks →

Quarterly Figures

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 -1.69 702 119.10 -8.50 -58 -74
2025: Q1 -1.15 824 151.80 -5.00 65 42
2025: Q2 -0.51 839 154.70 -2.10 0 -13
2025: Q3 -1.12 839 152.60 -4.80 96 81
2025: Q4 -0.96 792 12.80 -4.30 2 -13
2026: Q1 -0.51 796 -3.40 -2.30 87 73
What Do These Terms Mean?
EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Annual Figures

Annual Figures
Fiscal Year Revenue ($M) EBIT ($M) Net Income ($M) EPS ($) Operating Cash Flow ($M) Equity ($M) Total Assets ($M)
2016 761 -22 22 0.64 31 654 1,521
2017 800 33 8 0.23 53 709 1,731
2018 866 22 -178 -5.28 -6 539 1,340
2019 928 55 -22 -0.63 103 556 1,284
2020 917 49 21 0.62 109 578 1,287
2021 1,085 29 7 0.20 71 543 1,881
2022 1,491 -164 -194 -5.63 -41 318 1,647
2023 1,386 3 -79 -2.28 -26 257 1,564
2024 2,187 -141 -154 -4.41 192 2,139 2,807
2025 3,204 94 -159 -4.48 103 1,064 3,989

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

About the Company

Magnera Corporation fertigt und verkauft weltweit Vliesstoffe und verwandte Produkte. Es verkauft seine Produkte vorwiegend in verbraucherorientierte Endmärkte wie Gesundheitswesen und Körperpflege.

Employees8,000
HeadquartersCharlotte, NC
Address9335 Harris Corners Pkwy, 28269 Charlotte, United States
Phone866 744 7380
Websitemagnera.com
IPO Date16. May 1984
ISINUS55939A1079
Stock Split1:13 on 11/04/2024

Management

Management
Name Title Birth Year
Curtis L. Begle CEO, President & Director 1975
James M. Till Executive VP, CFO & Treasurer 1978
Tarun Manroa Executive VP & COO 1981
Erin Maile Executive VP & Chief Accounting Officer 1992
Phil Lerro Chief Information Officer
Robert Weilminster Executive Vice President of Strategy, Integration, Corporate Development & Investor Relations
Jill L. Urey Executive VP, General Counsel & Corporate Secretary 1968
Paul Harmon Chief Innovation & Marketing Officer
Amanda Hart Chief Human Resources Officer
Kathy Vanderheyden Executive Vice President of Global Operations & Business Transformation

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Chart

Interactive price chart (TradingView).

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?